Asia-Pacific Cell and Gene Therapy Thawing Equipment Market, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centers, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast To 2028.
Market Analysis and Insights : Asia-Pacific Cell and Gene Therapy Thawing Equipment Market
The cell and gene therapy thawing equipment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 14.2% in the forecast period of 2021 to 2028 and is expected to reach USD 1,771.29 million by 2028. Increase in cases of genetic diseases such as cardiac ailments, cystic fibrosis and AIDS demands the advanced cell and gene therapy thawing equipment, thus acts as driver for the cell and gene therapy thawing equipment market growth.
Cell and gene therapy thawing equipment has become easy due to the advancement in technology as the number of the key market players are developing and launching new solutions to expand their market. Moreover, the rising healthcare expenditure in developed, as well as developing countries, has fueled the growth of the cell and gene therapy thawing equipment market. The cell and gene therapy thawing equipment market is growing due to the increased incidence of chronic diseases and the rise in technological advancement.
Increasing prevalence of chronic diseases acts as driver for the cell and gene therapy thawing equipment market. Rise in cost associated with cell and gene therapy engineering lowers the demand of cell and gene therapy thawing equipment which is restraining the cell and gene therapy thawing equipment market growth. Surge in novel technological advancement acts as an opportunity for the cell and gene therapy thawing equipment market. However, lac of accessibility in low and middle income countries acts as challenge for the cell and gene therapy thawing equipment market growth.
The cell and gene therapy thawing equipment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the cell and gene therapy thawing equipment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Cell and Gene Therapy Thawing Equipment Market Scope and Market Size
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of sample, the cell and gene therapy thawing equipment market is segmented into cell therapies and gene therapies. In 2021, the cell therapy segment is expected to dominate the cell and gene therapy thawing equipment market due to rising prevalence and incidence of cancer.
- On the basis of type, the cell and gene therapy thawing equipment market is segmented into manual thawing system and automatic thawing system. In 2021, the automatic thawing system segment is expected to dominate the cell and gene therapy thawing equipment market as it improves reproducibility and minimizes human error.
- On the basis of application, the cell and gene therapy thawing equipment market is segmented into upstream processing and downstream processing. In 2021, the upstream processing segment is expected to dominate the cell and gene therapy thawing equipment market due to rising technological advancements in the thawing systems.
- On the basis of end user, the cell and gene therapy thawing equipment market is segmented into blood banks and transfusion centers, hospitals and diagnostic laboratories, research laboratories and academic institutes, biotechnology and pharmaceutical industry, cord blood and stem cell banks, gene banks and others. In 2021, the blood banks segment is expected to dominate the Cell and gene therapy thawing equipment market due to rise in number of blood banks and advanced healthcare providers in low and middle income countries.
- On the basis of distribution channel, the cell and gene therapy thawing equipment market is segmented into direct tender, third part distributor and others. In 2021, the direct tender segment is expected to dominate the cell and gene therapy thawing equipment market as majority of healthcare provider’s procured cell and gene therapy thawing equipment right from direct tender.
Cell and Gene Therapy Thawing Equipment Market Country Level Analysis
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel.
The countries covered in the cell and gene therapy thawing equipment market report are Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and rest of Asia-Pacific.
China is leading the growth of the Asia-Pacific market and Benchtop segment is dominating in this country due to presence of highest number of cell and gene therapy thawing equipment providers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and Gene Therapy Thawing Equipment is boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market
The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Cell and Gene Therapy Thawing Equipment Market Share Analysis
Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Cell and gene therapy thawing equipment market.
The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the cell and gene therapy thawing equipment market.
For instance,
- In November 2020, Eppendorg AG had launched the SmartBlock for Cell Thawing in India. The Smart Block Cell Thawing is a foundation for downstream processing. It is easy and convenient for scientists for further use in every cell handling lab.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the cell and gene therapy thawing equipment market which also provides the benefit for organization’s profit growth.
SKU-